SCHEMBL31207927

SCHEMBL31207927

C=Cc1ccccc1-c1cnccc1C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4C Q9H3R0 15/20 0.44
▸ KDM6B O15054 8/20 0.44
▸ KDM4D Q6B0I6 6/20 0.44
▸ KDM4E B2RXH2 2/20 0.44
▸ KDM4A O75164 2/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ THRB P10828 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ MAOA P21397 1/20 0.39
▸ MAOB P27338 1/20 0.39
▸ KDM5B Q9UGL1 2/20 0.38
▸ EGLN3 Q9H6Z9 1/20 0.38
▸ LTB4R2 Q9NPC1 1/20 0.38
▸ SLC22A12 Q96S37 1/20 0.38
▸ KDM5A P29375 1/20 0.37
▸ CCNC P24863 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26600023 1.00 KDM4C (0.44) KDM4CKDM6BKDM4DKDM4EKDM4A
SCHEMBL2557655 0.86 KDM4C (0.45) KDM4CKDM6BKDM4DKDM4EKDM4A
SCHEMBL26599922 0.83 KDM4E (0.49) KDM4EALDH1A1KMT2AL3MBTL1CCNC
SCHEMBL20593569 0.82 KDM4C (0.53) KDM4CKDM6BKDM4DKDM4EKDM4A
SCHEMBL27497610 0.82 CYP2C9 (0.49) KDM4EALDH1A1MAPTKMT2AL3MBTL1
SCHEMBL29749311 0.79 KDM4C (0.53) KDM4CKDM6BKDM4DKDM4EKDM4A
SCHEMBL21056702 0.79 KDM4C (0.53) KDM4CKDM6BKDM4DKDM4EKDM4A
SCHEMBL30782804 0.78 KDM4C (0.49) KDM4CKDM6BKDM4DKDM4EKDM4A
SCHEMBL28883633 0.78 KDM4C (0.49) KDM4CKDM6BKDM4DKDM4EKDM4A
SCHEMBL6870086 0.76 MYC (0.53) KDM4CKDM6BKDM4DKDM4EKDM4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118974043-A Polq inhibitor compounds and uses thereof 南京再明医药有限公司 2024-11-15 — — CN disclosed
Send feedback